These perturbations have been attributed to reduced serum PON1 activity in PCOS patients [58], its genetic underpinnings [59] partly explained with the significant findings of our study observed in LD1, involving rs854560 (L55M) and rs662 (Q192R). The gene discussed is PON1; the disease is polycystic ovary syndrome.